Helena Taflin

1.3k total citations
25 papers, 253 citations indexed

About

Helena Taflin is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Helena Taflin has authored 25 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Hepatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Helena Taflin's work include Colorectal Cancer Treatments and Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Helena Taflin is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Helena Taflin collaborates with scholars based in Sweden, Denmark and Norway. Helena Taflin's co-authors include Kristoffer Derwinger, Karl Kodeda, Yvonne Wettergren, Elinor Bexe Lindskog, Elisabeth Odin, Göran Carlsson, Oskar Hemmingsson, Boe Sandahl Sørensen, Anders Kindberg Boysen and Bengt Gustavsson and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Helena Taflin

22 papers receiving 252 citations

Peers

Countries citing papers authored by Helena Taflin

Since Specialization

Citations

This map shows the geographic impact of Helena Taflin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helena Taflin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helena Taflin more than expected).

Fields of papers citing papers by Helena Taflin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helena Taflin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helena Taflin. The network helps show where Helena Taflin may publish in the future.

Co-authorship network of co-authors of Helena Taflin

This figure shows the co-authorship network connecting the top 25 collaborators of Helena Taflin. A scholar is included among the top collaborators of Helena Taflin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helena Taflin. Helena Taflin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-liver comorbidity in patients with hepatocellular carcinoma and curative treatments – a Swedish national registry study 2025 ·Scandinavian Journal of Gastroenterology ·Malin Sternby Eilard, (unknown), Magnus Rizell, Juan Vaz, Fredrik Åberg, Helena Taflin	0
2	Robotic-assisted contra open resection for suspected or confirmed gallbladder cancer (ROBOCOP) 2024 ·BJS Open ·Henrik Wallgren, (unknown), Helena Taflin, Caroline Williamsson, Stefan Gilg, (unknown), Malin Sternby Eilard, (unknown), Melroy A. D’Souza, Linda Lundgren, Christian Cahlin, Bodil Andersson, Ernesto Sparrelid, Per Sandström, Niclas Kvarnström, Magnus Rizell, Jenny Rystedt, Bergþór Björnsson, Christian Sturesson	0
3	Increased potentiation of 5-fluorouracil induced thymidylate synthase inhibition by 5,10-methylenetetrahydrofolate (arfolitixorin) compared to leucovorin in patients with colorectal liver metastases; The Modelle-001 Trial 2024 ·SHILAP Revista de lepidopterología ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Oskar Hemmingsson, Yvonne Wettergren, Krzysztof Urbanowicz, Jacek Turyn, Ryszard T. Smoleński, Godefridus J. Peters	4
4	Proteomic profiling of tumour tissue‐derived extracellular vesicles in colon cancer 2024 ·SHILAP Revista de lepidopterología ·Aleksander Cvjetkovic, Nasibeh Karimi, Rossella Crescitelli, Annika Thorsell, Helena Taflin, Cecilia Lässer, Jan Lötvall	6
5	The Resection Rate of Synchronously Detected Liver and Lung Metastasis from Colorectal Cancer Is Low—A National Registry-Based Study 2023 ·Cancers ·Jennie Engstrand, Helena Taflin, Jenny Rystedt, Oskar Hemmingsson, (unknown), Per Sandström, Bergþór Björnsson, Kristina Hasselgren	3
6	Increasing Dosage of Leucovorin Results in Pharmacokinetic and Gene Expression Differences When Administered as Two-Hour Infusion or Bolus Injection to Patients with Colon Cancer 2022 ·Cancers ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren, Elinor Bexe Lindskog	2
7	SOULMATE: the Swedish study of liver transplantation for isolated colorectal cancer liver metastases not suitable for operation or ablation, compared to best established treatment—a randomized controlled multicenter trial 2022 ·Trials ·(unknown), Helga Hagman, Johan Haux, Carl Jorns, Per Lindnér, Helena Taflin	11
8	A Fraction of CD8+ T Cells from Colorectal Liver Metastases Preferentially Repopulate Autologous Patient-Derived Xenograft Tumors as Tissue-Resident Memory T Cells 2022 ·Cancers ·Frank Liang, Lisa M. Nilsson, (unknown), (unknown), Helena Taflin, Jonas A. Nilsson, Ulf Yrlid	7
9	Prolonged postoperative length of stay may be a valuable marker for susceptibility to relapse beyond established risk factors in patients with stage III colon cancer 2022 ·World Journal of Surgical Oncology ·(unknown), Helena Taflin, Göran Carlsson, David Ljungman, Elinor Bexe Lindskog	0
10	A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer 2022 ·ESMO Open ·Göran Carlsson, Anna Koumarianou, Tormod Kyrre Guren, (unknown), (unknown), Nikolaos Kentepozidis, Per Pfeiffer, Morten Brændengen, D. Mavroudis, Helena Taflin, (unknown), Roger Tell, Christos Papadimitriou	1
11	Pharmacokinetics of preoperative intraperitoneal 5-FU in patients with pancreatic ductal adenocarcinoma 2021 ·Cancer Chemotherapy and Pharmacology ·Mikael Öman, Yvonne Wettergren, Elisabeth Odin, (unknown), Peter Naredi, Oskar Hemmingsson, Helena Taflin	19
12	Plasma deoxyuridine as a surrogate marker for toxicity and early clinical response in patients with metastatic colorectal cancer after 5-FU-based therapy in combination with arfolitixorin 2020 ·Cancer Chemotherapy and Pharmacology ·Helena Taflin, Elisabeth Odin, Göran Carlsson, Roger Tell, Bengt Gustavsson, Yvonne Wettergren	3
13	Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control study 2020 ·European Journal of Surgical Oncology ·(unknown), (unknown), Helena Taflin, Anne Andersson, Malin Sund, Oskar Hemmingsson	16
14	Quality-of-life after bile duct injury repaired by hepaticojejunostomy: a national cohort study 2020 ·Scandinavian Journal of Gastroenterology ·Christian Sturesson, Oskar Hemmingsson, C. Månsson, Per Sandström, C. Strömberg, Helena Taflin, Jenny Rystedt	2
15	Relationship between folate concentration and expression of folate-associated genes in tissue and plasma after intraoperative administration of leucovorin in patients with colorectal cancer 2018 ·Cancer Chemotherapy and Pharmacology ·Helena Taflin, Elisabeth Odin, Kristoffer Derwinger, Göran Carlsson, Bengt Gustavsson, Yvonne Wettergren	7
16	Methodological development and biological observations of cell free DNA with a simple direct fluorescent assay in colorectal cancer 2018 ·Clinica Chimica Acta ·Anders Kindberg Boysen, Brita Singers Sørensen, (unknown), (unknown), Julia S. Johansen, Benny Vittrup Jensen, Jakob Vasehus Schou, Finn Ole Larsen, Dorte Nielsen, Helena Taflin, (unknown), Yvonne Wettergren, Boe Sandahl Sørensen, Anne Hansen Ree, Svein Dueland, Niels Pallisgaard, K.-L.G. Spindler	12
17	ISO-CC-005; A phase I/II study of arfolitixorin (MTHF) in combination with 5-FU, irinotecan, and oxaliplatin ± bevacizumab in patients with metastasizing colorectal cancer 2018 ·Annals of Oncology ·Göran Carlsson, Tormod Kyrre Guren, Johan Haux, Per Pfeiffer, Helena Taflin, D. Mavroudis, Vassilis Georgoulias, C. Papadimitriou, (unknown), Dimitrios Boumpas, (unknown), (unknown), Bengt Gustavsson	1
18	A pharmacokinetic and pharmacodynamic investigation of Modufolin® compared to Isovorin® after single dose intravenous administration to patients with colon cancer: a randomized study 2014 ·Cancer Chemotherapy and Pharmacology ·Yvonne Wettergren, Helena Taflin, Elisabeth Odin, Karl Kodeda, Kristoffer Derwinger	10
19	Folate levels measured by LC–MS/MS in patients with colorectal cancer treated with different leucovorin dosages 2014 ·Cancer Chemotherapy and Pharmacology ·Helena Taflin, Yvonne Wettergren, Elisabeth Odin, Kristoffer Derwinger	20
20	Tumour differentiation grade is associated with TNM staging and the risk of node metastasis in colorectal cancer 2009 ·Acta Oncologica ·Kristoffer Derwinger, Karl Kodeda, Elinor Bexe Lindskog, Helena Taflin	77

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact